A Look at Cellebrite DI Ltd. (CLBT) Shares in the Recent Past Indicates Growth

Cellebrite DI Ltd. (NASDAQ: CLBT) stock jumped 7.84% on Monday to $4.95 against a previous-day closing price of $4.59. With 0.94 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.16 million shares. During the session, the Software – Infrastructure company that operates in wider Technology sector, reached to the highest price of $5.1350 whereas the lowest price it dropped to was $4.5100. The 52-week range on CLBT shows that it touched its highest point at $8.31 and its lowest point at $3.80 during that stretch. It currently has a 1-year price target of $7.10.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLBT was up-trending over the past week, with a rise of 12.76%, but this was up by 19.28% over a month. Three-month performance surged to 7.84% while six-month performance fell -10.49%. The stock lost -21.43% in the past year, while it has gained 13.53% so far this year. A look at the trailing 12-month EPS for CLBT yields 0.87 with Next year EPS estimates of 0.15. For the next quarter, that number is 0.04. This implies an EPS growth rate of -75.00% for this year and 148.39% for next year.

Float and Shares Shorts:

At present, 183.28 million CLBT shares are outstanding with a float of 45.03 million shares on hand for trading. On Oct 13, 2022, short shares totaled 1.42 million, which was 0.75% higher than short shares on Sep 14, 2022. In addition to Mr. Yossi Carmil as the firm’s Founder, CEO & Director, Ms. Dana Gerner serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 17.93% of CLBT’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 13.50% of CLBT, in contrast to 1.29% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in CLBT with 3.51% of the stake, Light Street Capital Management L holds 6,662,143 shares worth 6,662,143. A second-largest stockholder of CLBT, Excellence Investments Ltd., holds 5,952,877 shares, controlling over 3.14% of the firm’s shares. Greenhaven Road Investment Manage is the third largest shareholder in CLBT, holding 3,472,376 shares or 1.83% stake.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLBT since 6 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CLBT analysts setting a high price target of $10.00 and a low target of $5.00, the average target price over the next 12 months is $7.10. Based on these targets, CLBT could surge 102.02% to reach the target high and rise by 1.01% to reach the target low. Reaching the average price target will result in a growth of 43.43% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CLBT will report FY 2022 earnings on 02/14/2024. Analysts have provided yearly estimates in a range of $0.72 being high and $0.60 being low. For CLBT, this leads to a yearly average estimate of $0.66. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Cellebrite DI Ltd. surprised analysts by $0.13 when it reported $0.13 EPS against a consensus estimate of $0.01. The surprise factor in the prior quarter was $0.16. Based on analyst estimates, the high estimate for the next quarter is $0.12 and the low estimate is $0.01. The average estimate for the next quarter is thus $0.05.

Leave a Comment

Your email address will not be published. Required fields are marked *